Skip to Main Content
Hospital Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Cardiology
  4. Antithrombotics
  5. Treatment

Treatment

  • Angina (15)
  • Antithrombotics (277)
    • Drug-Induced Thrombosis (28)
    • Prevention (44)
    • Reversal (22)
    • Treatment (252)
      • Apixaban (Eliquis) (96)
      • Aspirin (130)
      • Cangrelor (Kengreal) (4)
      • Clopidogrel (Plavix) (76)
      • Dabigatran (Pradaxa) (98)
      • Edoxaban (Savaysa) (39)
      • Low Molecular Weight Heparins (60)
      • Other (39)
      • Prasugrel (Effient) (40)
      • Rivaroxaban (Xarelto) (104)
      • Ticagrelor (Brilinta) (38)
      • Vorapaxar (Zontivity) (1)
      • Warfarin - Drug Interactions (28)
      • Warfarin - Treatment (118)
  • Arrhythmias (127)
  • Blood Pressure (31)
  • Cardiovascular Disease and Depression (6)
  • Cholesterol (19)
  • CPR (6)
  • Dyslipidemia (164)
  • Endocarditis (21)
  • Heart Disease (74)
  • Heart Failure (149)
  • Hypertension (214)
  • Hypotension (26)
  • Ischemic Heart Disease/Acute Coronary Syndromes (234)
  • Myocardial Infarction (43)
  • Peripheral Vascular Disease (8)
  • Raynaud's (2)
  • Resources (675)
  • Stroke (114)
121 - 135 of 252 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Weigh the Risks and Benefits of DOACs for Venous Thromboembolism March 2016
Article: Don't Delay Restarting Anticoagulation in Atrial Fib Patients After GI Bleeding February 2016
PL Voices: Restarting Anticoagulation in Atrial Fibrillation After a GI Bleed February 2016
Other: Safety of Long-Term Treatment with Clopidogrel (Plavix) January 2016
Article: Implement a Therapeutic Interchange for Durlaza to Low-Dose Aspirin December 2015
Commentary: New Formulation: Durlaza (Aspirin Extended-Release) December 2015
PL Voices: Praxbind (idarucizumab) to Reverse Bleeding with Pradaxa (dabigatran) December 2015
Article: Add Idarucizumab To Your DOAC Reversal Protocol for Dabigatran December 2015
Commentary: New Drug: Kengreal (Cangrelor) October 2015
Article: Use a Checklist to Help Patients Safely Take DOACs October 2015
Article: Watch for Hypoglycemia in Patients Taking Repaglinide Plus Clopidogrel October 2015
Commentary: Oral Anticoagulants: Maximizing Safety October 2015
Checklist: Monitoring Checklist for the New Oral Anticoagulants October 2015
PL Voices: Monitoring Direct Oral Anticoagulants October 2015
PL Voices: How to Choose an Antiplatelet Agent to Prevent Recurrent Stroke September 2015
  • « Prev
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved